Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of apoptosis-specific eIF-5A siRNA to down regulate expression of proinflammatory cytokines to treat sepsis

Use of apoptosis-specific eIF-5A siRNA to down regulate expression of proinflammatory cytokines to treat sepsis

US Patent 8193158 · Granted Jun 5, 2012

Estimated economic value: $399,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for treating cardiovascular diseases2025
Compositions and methods of use of alpha-1 antitrypsin fusion polypeptides2024
Methods for treating melanoma2024
Methods for treating cardiovascular diseases2023
IL-37 fusion protein and methods of making and using same2022
Method for preventing or treating Alzheimer's disease2022
Plants with modified deoxyhypusine synthase genes2021
Compositions and methods for preparing a subject for organ or non-organ implanta2020
Method for treating multiple sclerosis2020
Compositions, methods and uses for alpha-1 antitrypsin fusion molecules2019
Compositions of alpha-1 antitrypsin fusion molecules2019
Compositions, methods and uses for alpha-1 antitrypsin fusion molecules2018